<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
New York, New York–(Newsfile Corp. – October 29, 2021) – Pomerantz LLP is investigating claims on behalf of investors of Novavax, Inc. (“Novavax” or the “Company”) (NASDAQ: NVAX). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.The investigation concerns whether Novavax and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the…
...read full article on Newsfile Corp
